| Product Name | MF | CAS | Details |
|---|
| n-Octyl-beta-D-thiogalactopyranoside | C14H28O5S | 42891-16-7 | Details |
| 2-Methylbut-3-yn-2-yl carbamate | C6H9NO2 | 33060-69-4 | Details |
| 4-Chloro-2-(1H-1,2,4-triazol-1-yl)benzaldehyde | C9H6ClN3O | 1310531-91-9 | Details |
| SPR Blocking Peptide | Details |
| 2-(Oxan-4-yloxy)ethan-1-amine | C7H15NO2 | 933758-57-7 | Details |
| 4-(Propan-2-yloxy)benzene-1-thiol | C9H12OS | 702-12-5 | Details |
| 1,2,4-Trimethoxybenzene | C9H12O3 | 135-77-3 | Details |
| Vanadyl phthalocyanine | C32H16N8OV | 13930-88-6 | Details |
| LIMKi 3 | C17H14Cl2F2N4OS | 1338247-35-0 | Details |
| 2-Bromo-1-(2,4,6-trifluorophenyl)propan-1-one | C9H6BrF3O | 1152568-77-8 | Details |
| CYP4A11 antibody | Details |
| Benzimidazole-5-carboxylic acid | C8H6N2O2 | 15788-16-6 | Details |
| 5-Bromo-2-cyclobutylpyridine | C9H10BrN | 1159815-16-3 | Details |
| 3-(1-Hydroxy-1-methylethyl)benzoic acid | C10H12O3 | 40912-34-3 | Details |
| R-Afatinib | C24H25ClFN5O3 | 439081-17-1 | Details |
| Bococizumab | 1407495-02-6 | Details |
| 1,4-Dioxaspiro[4.5]decane-8-sulfonyl chloride | C8H13ClO4S | 1262407-55-5 | Details |
| 3-Deazaadenosine | C11H14N4O4 | 6736-58-9 | Details |
| 2-(4-tert-Butylphenyl)acetaldehyde | C12H16O | 109347-45-7 | Details |
| 4-Chloro-2-methyl-5-nitroaniline | C7H7ClN2O2 | 34648-99-2 | Details |
| ERMAP Blocking Peptide | Details |
| 5-Bromo-1-(difluoromethyl)-1H-indole | C9H6BrF2N | 1594578-70-7 | Details |
| Lepirudin | C287H440N80O111S6 | 138068-37-8 | Details |
| 3-Amino-4-methylpiperidin-2-one | C6H12N2O | 53611-43-1 | Details |
| Ractopamine hydrochloride - 97% | C18H24ClNO3 | 90274-24-1 | Details |
| DSPE-PEG(2000) carboxylic acid sodium | (C2H4O)nC45H86NO12P.Na | 1403744-37-5 | Details |
| 1-Methyl-2,3-O-isopropylidene-1,4-dideoxy-1,4-imino-1-N-dehydro-D-ribitol | C9H15NO3 | 909703-52-2 | Details |
| 2-O-Hexadecyl-rac-glycero-3-phosphocholine | Details |
| (Benzyloxy)(methyl)amine | C8H11NO | 22513-22-0 | Details |
| Poly(4-hydroxy-2,2,6,6-tetramethyl-1-piperidine ethanol-alt-1,4-butanedioic acid) - Technical | C17H33NO6 | 65447-77-0 | Details |
| 2-Benzoyl-2-azabicyclo[2.1.1]hexane-1-carboxylic acid | C13H13NO3 | 1909336-08-8 | Details |
| Hepatitis C Virus protein (His tag) | Details |
| 2-Hydroxy-2-(o-chlorophenyl)cyclohexanone | C12H13ClO2 | 1823362-29-3 | Details |
| 2-(5-Bromothiophen-2-yl)pyrimidin-5-amine | C8H6BrN3S | 1094373-80-4 | Details |
| 3-[3-(Trifluoromethyl)phenoxy]propane-1-sulfonyl chloride | C10H10ClF3O3S | 1340078-21-8 | Details |
| 1-(Furan-2-carbonyl)piperidine-3-carboxylic acid | C11H13NO4 | 436093-09-3 | Details |
| Spermidine trihydrochloride | C7H22Cl3N3 | 334-50-9 | Details |
| Z-Ala-Ala-Asn-AMC | C28H31N5O8 | 149697-16-5 | Details |
| Elastin antibody | Details |
| 2-[2-(2-Naphthalenyl)ethoxy]adenosine | C22H23N5O5 | 131865-99-1 | Details |
| Adecatumumab | 503605-66-1 | Details |
| 2-[3-(methoxycarbonyl)bicyclo[1.1.1]pentan-1-yl]acetic acid | C9H12O4 | 1113001-63-0 | Details |
| 5-Bromosalicylic acid methyl ester | C8H7BrO3 | 4068-76-2 | Details |
| H-LLIYAASSLQSGVPSR^-OH | Details |
| Cetyltrimethylammonium chloride | C19H42ClN | 112-02-7 | Details |
| 5-Carbamoyl-1-phenyl-1H-pyrazole-3-carboxylic acid | C11H9N3O3 | 1311315-98-6 | Details |
| 2-Bromothiobenzamide | C7H6BrNS | 30216-44-5 | Details |
| 2-Fluoro-6-nitrotoluene | C7H6FNO2 | 769-10-8 | Details |
| 4,4-Dimethoxytetrahydro-2H-pyran-3-ol | C7H14O4 | 104681-92-7 | Details |
| 4-(Tributylstannyl)thiazole | C15H29NSSn | 173979-01-6 | Details |
| CD105 protein | Details |
| H-ALGTEVIQLFPEK^-OH | Details |
| RPS2 protein (His tag) | Details |
| 2,4-Dinitro-5-methylphenylhydrazine | C7H8N4O4 | 5267-23-2 | Details |
| UBE2D3 protein (His tag) | Details |
| H-DGRGDS-OH | Details |
| Imidazo[1,2-a]pyrazine-8-carboxylic acid hydrochloride | C7H6ClN3O2 | 1820735-11-2 | Details |
| 2-(3-Hydroxyphenyl)ethyl alcohol | C8H10O2 | 13398-94-2 | Details |
| (5-Bromo-3-methylpyridin-2-yl)methanamine | C7H9BrN2 | 886365-53-3 | Details |
| Disopyramid phosphate | C21H32N3O5P | 22059-60-5 | Details |
| FAM121B Blocking Peptide | Details |
| Bisdemethoxycurcumin | C19H16O4 | 22608-12-4 | Details |
| 3-Deoxy-3-fluoro-D-galactose - Aqueous solution | C6H11FO5 | 52904-86-6 | Details |
| 3-(Pyridin-4-yl)-1H-pyrazole-5-carbaldehyde | C9H7N3O | 865610-72-6 | Details |
| 2-Amino-5-hydroxypyridine-3-carboxylic acid hydrochloride | C6H7ClN2O3 | 1955554-78-5 | Details |
| 1,4-Sorbitan | Details |
| 2-(5-Methylpyridin-3-yl)acetic acid hydrochloride | C8H10ClNO2 | 1787905-81-0 | Details |
| 2-Chloro-5-fluoroquinoxaline | C8H4ClFN2 | 55687-09-7 | Details |
| MRS2L antibody | Details |
| 3-Amino-1-(3-fluoro-4-methoxyphenyl)thiourea | C8H10FN3OS | 1096922-85-8 | Details |
| 2-Acetamido-6-O-(a-2-N-acetylneuraminyl)-2-deoxy-a-D-galactopyranosyl threonine | Details |
| Nelfinavir-d3 | C32H42D3N3O4S | 1217629-70-3 | Details |
| 6,6-Dimethylpiperidin-2-one hydrochloride | C7H14ClNO | 2377030-71-0 | Details |
| Rat anti-Mouse IgD antibody (FITC) | Details |
| DOTA-tris(TBE)-Amido-dPEG?12-TFP Ester | Details |
| (2-Methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methanamine dihydrochloride | 37039-52-4 | Details |
| 1-[3-(Pyrrolidin-1-yl)propyl]-1H-pyrazol-3-amine | C10H18N4 | 1249320-61-3 | Details |
| 2,6-Dimethylphenylthiourea | C9H12N2S | 6396-76-5 | Details |
| 5-Ethoxy-1H-pyrazole-3-carboxylic acid | C6H8N2O3 | 89831-43-6 | Details |
| HXB2 gag NO-102/aa405 - 419 | C73H124N26O18S3 | Details |
| (2,3-Dihydro-[1,4]dioxino[2,3-b]pyridin-2-yl)methanol | C8H9NO3 | 153332-63-9 | Details |
| Clorgyline Hydrochloride | C13H16Cl3NO | 17780-75-5 | Details |
| 1-(Thiophen-2-ylmethyl)-1H-pyrrole-2-carboxylic acid | C10H9NO2S | 1016863-52-7 | Details |
| 2-(4-Methoxycyclohexyl)acetic acid | C9H16O3 | 99183-14-9 | Details |
| 4-Nitrophenyl hexanoate | C12H15NO4 | 956-75-2 | Details |
| (+)-Lariciresinol 4'-o-beta-D-glucopyranosyl-(1->3)-beta-D-glucopyranoside | C32H44O16 | 639857-95-7 | Details |
| N-(2-methylquinolin-4-yl)-1-phenylcyclopentane-1-carboxamide | C22H22N2O | 1024081-77-3 | Details |
| 2-(4-Hydroxy-3-methylphenyl)acetonitrile | C9H9NO | 73653-24-4 | Details |
| 4-(Morpholin-4-yl)-2-(trifluoromethyl)aniline | C11H13F3N2O | 78335-26-9 | Details |
| CLPP antibody | Details |
| POTED antibody | Details |
| D-Galactopyranosyl-(b1-3)-[N-acetylneuraminyl-(a2-6)]-D-N-acetylgalactosaminyl serine-biotin | Details |
| 3-[4-(Benzyloxy)phenyl]prop-2-enal | C16H14O2 | 84184-53-2 | Details |
| 2-{[4-(Morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}acetic acid | C8H11N3O4S | 66950-03-6 | Details |
| CD16 antibody (PE) | Details |
| 5-(1-Methylcyclopropyl)-1,2-oxazol-3-amine | C7H10N2O | 95924-26-8 | Details |
| Trans 4-dimethylaminocrotonic acid-d6 hydrochloride | C6H12ClNO2 | 1259519-59-9 | Details |
| H-SVSEIQLMHNLGK^^-OH | Details |
| 5-(Benzyloxy)-3H-spiro[1-benzofuran-2,1'-cyclopropane]-3-one | C17H14O3 | 72492-09-2 | Details |
| Hemoglobin epsilon antibody | Details |
| Product Total： Product Page： | ||||
| 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 | ||||